Idorsia (LTS:0RQE) Accounts Payable : CHF18.4 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Accounts Payable?

Idorsia's Accounts Payable for the quarter that ended in Sep. 2023 was CHF18.4 Mil.

Idorsia's quarterly Accounts Payable declined from Mar. 2023 (CHF27.1 Mil) to Jun. 2023 (CHF24.8 Mil) and declined from Jun. 2023 (CHF24.8 Mil) to Sep. 2023 (CHF18.4 Mil).

Idorsia's annual Accounts Payable increased from Dec. 2020 (CHF11.1 Mil) to Dec. 2021 (CHF26.9 Mil) but then declined from Dec. 2021 (CHF26.9 Mil) to Dec. 2022 (CHF25.4 Mil).

Idorsia Accounts Payable Historical Data

The historical data trend for Idorsia's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Accounts Payable Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Payable

Get a 7-Day Free Trial

7.13

8.76

11.12

26.86

25.44

Idorsia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accounts Payable	Get a 7-Day Free Trial															19.37	25.44	27.11	24.80	18.37

Idorsia Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Idorsia Accounts Payable Related Terms

Thank you for viewing the detailed overview of Idorsia's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia (LTS:0RQE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (LTS:0RQE) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

IDRSF:USA IDIAz:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.

Idorsia (LTS:0RQE) Headlines

No Headlines